Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2026

Feb 11, 2026

29745_dirs_2026-02-11_af66a08c-5d72-4bdc-be62-47b00ea5f6dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-09

Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-09 Common Stock A 583.784 $1044.67 Acquired 3423.443 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-09 Restricted Stock Unit $ A 199.472 Acquired 2029-02-16 Common Stock (199.472) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1728.57 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.